Characterization of liver metastasis and its impact on targeted therapy in EGFR mutant NSCLC: A multicenter study

The risk factors of liver metastasis (LM) in patients with non-small-cell lung cancer (NSCLC) remain unknown. Whether LM predicts the effect of first-line EGFR-tyrosine kinase inhibitors (TKIs) in patients with EGFR-mutant NSCLC needs to be explored.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qMQmm3
via IFTTT